Using low-sodium salt to improve heart failure outcomes
Official title: Effects of Low-Sodium Substitute Salt on Death, Heart Failure Hospitalization, Heart Failure Emergency Department Visits, and Quality of Life in Patients With Heart Failure: A Multicenter, Double-Blind, Randomized Controlled Trial
Run by Heart Health Research Center · NCT06764225 · Data updated 2026-11-12
This study is testing if using low-sodium salt can help people with heart failure feel better and stay out of the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 1301 (estimated) |
| Sponsor | Heart Health Research Center Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | April 3, 2025 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | May 21, 2025 |
| Trial ID | NCT06764225 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 who have been hospitalized for heart failure within the past year and have stable heart failure.
✕Probably not a fit
Patients with end-stage heart failure or uncontrolled health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of a low-sodium substitute salt on patients with heart failure. It employs a randomized, double-blind, controlled design, assigning participants to either the low-sodium salt group or a control group using regular salt. Over the course of a year, the study will assess outcomes such as mortality rates, hospital readmissions, emergency visits, and quality of life improvements through questionnaires. The goal is to determine if dietary sodium reduction can lead to better health outcomes for heart failure patients.
Why it matters
Potential benefit: If successful, this study could provide a simple dietary intervention that significantly improves health outcomes for heart failure patients.
How similar studies have gone: Other studies have shown promising results with dietary sodium reduction in heart failure management, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged between 18 and 75 years; 2. Hospitalized due to heart failure in the past year; 3. NYHA functional class II-III; 4. Echocardiographic evidence of LVEF \< 40% within the past 6 months; 5. Receiving guideline-directed medical therapy for heart failure; 6. Stable heart failure status, defined as heart failure stability for more than 4 weeks, with no increase in diuretic dose within the past 4 weeks; 7. Having a primary caregiver and frequently dining together at home; 8. Consuming commercially processed food no more than once a week; 9. Providing written informed consent. Exclusion Criteria: 1. End-stage heart failure; 2. Hospitalization due to cardiovascular causes within the past month; 3. Uncorrected hyponatremia (Na \< 130 mmol/L); 4. Dialysis-dependent patients, or eGFR \< 20 mL/min/1.73m²; 5. Uncontrolled hyperglycemia, with fasting blood glucose \> 16 mmol/L; 6. Malignant cancer patients with a life expectancy of less than 1 year; 7. Conditions that, in the investigator's opinion, may interfere with adherence to the protocol, such as habitual reliance on takeout meals or dining at company cafeterias; 8. Planned hospitalization during the study period; 9. Unexplained weight loss greater than 5 kg in the past year; 10. The subject or family members have concerns about using the salt substitute in this study, or are planning for pregnancy, pregnant, or breastfeeding; 11. Another family member is already participating in this study; 12. The subject or family members are participating in other interventional clinical trials.
Where it's running
-
Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Xin Du
- Email: duxinheart@sina.com
- Phone: +86-64456862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.